Two physicians in Cardiovascular Medicine take a closer look at the effect of statin therapy on function and quality of life for frail older adults. They provide recommendations based on an evidence-informed appraisal of the literature.
From heart benefits of diabetes drugs to leadless pacing to expanding populations for TAVR, 2016 was a dynamic year in cardiovascular care. Cleveland Clinic experts reflect on a dozen key developments.
Ezetimibe adds to the LDL-lowering power of statin therapy, and achieving very low LDL levels further lowers cardiovascular risk.
What do gut flora and the proliferation of percutaneous procedures have in common? They both figure into discoveries or changes from our list of 50 key developments in cardiovascular care over the past two decades.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
New guidelines emphasizing the use of statins in high-risk populations are well supported by clinical evidence, but do not offer clear guidance on populations falling outside these boundaries.
There are many options that may allow a patient to benefit from statin therapy without incurring side effects.